Article Contents ::
- 1 The Brand Name FURACIN Has Generic Salt :: Nitrofurazone
- 2 FURACIN Is From Company Gsk Priced :: Rs. 29.81/189.62
- 3 FURACIN have Nitrofurazone is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name FURACIN Has Generic Salt :: Nitrofurazone
FURACIN Is From Company Gsk Priced :: Rs. 29.81/189.62
FURACIN have Nitrofurazone is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| Nitrofurazone | OINT | Rs. 29.81/189.62 | 25/500;G |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 25/500;G |
| FURACIN | Gsk | 0.2%W/W | 25/500;G | Rs. 29.81/189.62 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From Gsk :: FURACIN | Nitrofurazone | #N/A | #N/A |
Indications for Drugs ::
Burns, Wounds, Skin infections, Skin grafting, Ulcers
Drug Dose ::
Adult: Apply as 0.2% topical preparation in a water-soluble or water-miscible basis to the affected area.
Contraindication ::
Hypersensitivity. Cross-sensitation may occur with other nitrofuran derivatives.
Drug Precautions ::
G6PD deficiency (oral). Renal impairment.
Drug Side Effects ::
Oral: Severe peripheral neuropathy. Topical: Sensitisation, generalised allergic skin reactions.
Pregnancy category ::
2
Drug Mode of Action ::
Bactericidal against a wide spectrum of gram-negative and gram-positive bacteria. It also has activity against trypanosomes.
Drug Interactions ::
Reduced excretion with probenecid or sulfinpyrazone. Absorption reduced by magnesium trisilicate. Antagonistic effects with quinolone antibacterials. Reduced effects with carbonic anhydrase inhibitors or urinary alkalinisers.
